OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025 BULLW Webull Warr investors await full quarterly performance details as official earnings metrics remain undisclosed American Electric Power AEP Declares Regular Quarterly Common Dividend Extending 116Year Unbroken Payout Track Record Why Fangdd DUO is trading below its true worth Underperforming 20260506